The fusion oncoprotein product of the Philadelphia chromosome (Ph), Break-point cluster region-Abelson (BCR-ABL), is the critical driver for the pathogenesis of CML and acute lymphoblastic leukaemia (Ph + ALL).2 The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.